Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-07-22
2008-07-22
Weber, Jon P (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S300000, C530S350000, C424S094100
Reexamination Certificate
active
07402567
ABSTRACT:
The present invention relates generally to the treatment and prevention of diseases characterized by excess cell proliferation and/or activation. In particular, the present invention provides compositions and methods to suppress the activation and/or proliferation of various cells. In preferred embodiments, the present invention provides compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells (including, but not limited to hepatic stellate cells), as well as cells with abnormal growth characteristics. In particularly preferred embodiments, the present invention provides compositions and methods to induce fibrosis.
REFERENCES:
patent: 5215892 (1993-06-01), Kishimoto et al.
patent: 5192152 (1993-03-01), None
patent: WO 95/03326 (1995-02-01), None
Hutt et al., Signal Transducer and Activator of Transcription 3 Activates CCAAT Enhancer-binding Protein Gene Transcription in Go Growth-arrested Mouse Mammary Epithelial Cells and in Involuting Mouse Mammary Gland, 2000, vol. 275, pp. 29123-29131.
Akira et al. (1990) “A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family,” EMBO J. 9:1897-1906.
Alley et al. (1988) “Feasibility of Drug Screening with Panels of Human Tumor Cell Lines Using a Microculture Tetrazolium Assay,” Cancer Res. 48:589-601.
Andrade et al. (1998) “Granzyme B Directly and Efficiently Cleaves Several Downstream Caspase Substrates: Implications for CTL-Induced Apoptosis,” Immunity 8:451-460.
Ankoma-Sey and Friedman, “Hepatic stellate cells,” inLiver Growth and Repair, Strain and Diehl (eds.), Chapman & Hall, London, pp. 512-537, 1998.
Ashkenazi et al. (1998) “Death Receptors: Signaling and Modulation,” Science 281:1305-1308.
Beg et al. (1996) “An Essential Role for NF-B in Preventing TNF-Induced Cell Death,” Science 274:782-784.
Bhatt et al. (1999) “The Protein Kinase p90 Rsk as an Essential Mediator of Cytostatic Factor Activity,” Science 286:1362-1365.
Blanchard et al. (2000) “Caspase-8 Specificity Probed at Subsite S4: Crystal Structure of the caspase-8-Z-DEVD-cho Complex,” J. Mol. Biol. 302:9-16.
Bonni et al. (1999) “Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms,” Science 286:1358-1362.
Boshart et al. (1985) “A Very Strong Enhancer is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus,” Cell 41:521-530.
Boyle et al. (1991) “Phosphopeptide Mapping and Phosphoamino Acid Analysis by Two-Dimensional Separation of Thin-Layer Cellulose Plates,” Meth. Enzymol. 201:110-149.
Bravo et al. (1987) “Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ,” Nature 326:515-517.
Buck et al. (1999) “Phosphorylation of Rat Serine 105 or Mouse Threonine 217 in C/EBPβ Is Required for Hepatocyte Proliferation Induced by TGFα ,” Mol. Cell. 4:1087-1092.
Buck et al. (1994) “LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation,” EMBO J. 13:851-860.
Buck and Chojkier (1996) “Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants,” EMBO J. 15:1753-1765.
Cao (1991) “Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells,” Genes Dev. 5:1538-1552.
Caruthers et al. (1980) “New chemical methods for synthesizing polynucleotides,” Nuc. Acids Res. Symp. Ser. 215-223.
Chen et al. (1995) “Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway,” Genes Dev. 9:1586-1597.
Chen et al. (1995) “Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA,” Nature 374:386-388.
Chinery et al. (1997) “Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAFI/CIP1via C/EBPβ,” Nat. Med. 3:1233-1241.
Chojkier, “Pathogenesis of Hepatic Fibrosis,” inPathogenesis of Hepatic Fibrosis In Extracellular Matrix, Marcel Dekker Inc., NY, NY, pp. 541-557, 1993.
Chojkier, “Regulation of collagen gene expression,” inLiver Growth and Repair, Strain and Diehl (eds.), Chapman & Hall, London, pp. 430-450, 1998.
Descombes et al. (1990) “LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein,” Genes Dev. 4:1541-1551.
Dijkema et al. (1985) “Cloning and Expression of the Chromosomal Immune Interferon Gene of the Rat,” EMBO J. 4:761-767.
Earnshaw et al. (1999) “Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis,” Ann. Rev. Biochem. 68:383-424.
Friedman et al. (1989) Maintenance of Differentiated Phenotype of Cultured Rat Hepatic Lipocytes by Basement Membrane Matrix, J. Biol. Chem. 264:10756-10762.
Friedman et al. (1985) “Hepatic lipocytes: The principal collagen-producing cells of normal rat liver,” Proc. Natl. Acad. Sci. USA 82:8681-8685.
Garcia-Calvo et al. (1998) “Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors,” J. Biol. Chem. 273:32608-32613.
Gorman et al., “The Rous Sarcoma Virus Long Terminal Repeat is a Strong Promoter when Introduced into a Variety of Eukaryotic Cells by DNA-Mediated Transfection,” Proc. Natl. Acad. Sci. USA 79:6777-6781 (1982).
Graves et al. (2000) “Regulation of carbamoyl phosphate synthetase by MAP kinase,” Nature 403:328-332.
Green et al. (1998) “Mitochondria and Apoptosis,” Science 281:1309-1312.
Gross et al. (1999) “Induction of Metaphase Arrest in CleavingXenopusEmbryos by the Protein Kinase p90Rsk,” Science 286:1365-1367.
Harris et al. (1998) “Definition and Redesign of the Extended Substrate Specificity of Granzyme B,” J. Biol. Chem. 273:27364-27373.
Horn et al. (1980) “Synthesis of oligonucleotides on cellulose. Part II: design and synthetic strategy to the synthesis of 22 oligodeoxynucleotides coding for Gastric Inhibitory Polypeptide (GIP)1,” Nuc. Acids Res. Symp. Ser. 225-232.
Houglum et al. (1995) “Two Differentcis-acting Regulatory Regions Direct Cell-specific Transcription of the Collagen α1(I) Gene in Hepatic Stellate Cells and in Skin and Tendon Fibroblasts,” J. Clin. Invest. 96:2269-2276.
Houglum et al. (1995) “LAP (NF-IL6) Transactivates the Collage α1(I) Gene from a 5′ Regulatory Region,” J. Clin Invest. 94:808-814.
Joza et al. (2001) “Essential role of the mitochrondrial apoptosis-inducing factor in programmed cell death,” Nature 410:549-554.
Kim et al. (1990) “Use of the Human Elogation Factor 1α Promoter as a Versatile and Efficient Expression System,” Gene 91:217-223.
Lavoie et al. (1996) “Cyclin D1 Expression is Regulated Positively by the p42/44MAPKand Negatively by the p38/HOGMAPKPathway,” J. Biol. Chem. 271:20608-20616.
Lee et al. (1995) “Activation of Hepatic Stellate Cells by TGFα Collagen Type I is Mediated by Oxidative Stress Through c-mybExpression,” J. Clin. Invest. 96:2461-2468.
Lee et al. (1997) “Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway,” Cell 88:213-222.
Maher et al. (1990) “Extracellular Matrix Gene Expression Increases Preferentially in Rat Lipocytes and Sinusoidal Endothelial Cells during Hepatic Fibrosis In Vivo,” J. Clin. Invest. 86:1641-48.
Maniatis et al. (1987) “Regulation of Inducible and Tissue-Specific Gene Expression,” Science 236:1237-1245.
Mao et al. (1998) “Activation of Caspase-1 in the Nucleus Requires Nuclear Translocation of Pro-caspase-1 Mediated by its Prodomain,” J
Buck Martina
Chojkier Mario
Medlen & Carroll LLP
Mitra Rita
The Regents of the University of California
The United States of America as represented by the Department of
Weber Jon P
LandOfFree
Treatment of disease by inducing cell apoptosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of disease by inducing cell apoptosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of disease by inducing cell apoptosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2803689